Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
AVHHL Stock Summary
In the News
AVHHL Financial details
Company Rating
Neutral
Market Cap
397.86M
Income
-33.67M
Revenue
45.4M
Book val./share
247.93
Cash/share
236.67
Dividend
-
Dividend %
-
Employees
207
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
-0.02
Forward P/E
-32
PEG
-0
P/S
7.07
P/B
0.01
P/C
0.01
P/FCF
-11.51
Quick Ratio
5.58
Current Ratio
6.25
Debt / Equity
0.03
LT Debt / Equity
0.03
-
-
EPS (TTM)
-34.5
EPS next Y
-0.1
EPS next Q
-0.12
EPS this Y
-83.1%
EPS next Y
-99.71%
EPS next 5Y
-100.36%
EPS last 5Y
-9.25%
Revenue last 5Y
44.86%
Revenue Q/Q
16.1%
EPS Q/Q
41576.79%
-
-
-
-
SMA20
8.3%
SMA50
19.01%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-42%
ROE
-46%
ROC
-0.22%
Gross Margin
84%
Oper. Margin
-34%
Profit Margin
-74%
Payout
-
Shs Outstand
128.45M
Shs Float
128.45M
-
-
-
-
Target Price
-
52W Range
0.082-4.01
52W High
-
52W Low
-
RSI
58.92
Rel Volume
2.86
Avg Volume
210
Volume
600
Perf Week
-0.62%
Perf Month
15.52%
Perf Quarter
-
Perf Half Y
8.84%
-
-
-
-
Beta
1.383
-
-
Volatility
0.13%, 0.22%
Prev Close
0%
Price
3.2
Change
0%
AVHHL Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.09 | 0.14 | 0.26 | 1.87 | 0.3 | |
Net income per share | -0.39 | -0.41 | -0.23 | -1.42 | -0.24 | |
Operating cash flow per share | -0.3 | -0.22 | -0.23 | -1.02 | -0.17 | |
Free cash flow per share | -0.33 | -0.23 | -0.24 | -1.05 | -0.17 | |
Cash per share | 0.32 | 0.73 | 0.98 | 4.81 | 0.7 | |
Book value per share | 0.33 | 0.71 | 1.02 | -13.33 | 0.75 | |
Tangible book value per share | 0.33 | 0.71 | 1.02 | 6.01 | 0.74 | |
Share holders equity per share | 0.33 | 0.71 | 1.02 | -13.33 | 0.75 | |
Interest debt per share | 0 | 0.02 | 0.01 | 0 | 0.01 | |
Market cap | 590.86M | 40.68M | 260.75M | 52.37M | 2.39M | |
Enterprise value | 570.6M | -31.04M | 150.89M | -24.03M | -14.85M | |
P/E ratio | -24 | -0.97 | -9.81 | -1.51 | -0.09 | |
Price to sales ratio | 109.49 | 2.85 | 8.92 | 1.15 | 0.07 | |
POCF ratio | -30.7 | -1.79 | -10.07 | -2.11 | -0.13 | |
PFCF ratio | -28.54 | -1.72 | -9.63 | -2.05 | -0.12 | |
P/B Ratio | 28.32 | 0.56 | 2.25 | -0.16 | 0.03 | |
PTB ratio | 28.32 | 0.56 | 2.25 | -0.16 | 0.03 | |
EV to sales | 105.74 | -2.18 | 5.16 | -0.53 | -0.43 | |
Enterprise value over EBITDA | -23.08 | 0.75 | -5.69 | 0.72 | 0.57 | |
EV to operating cash flow | -29.64 | 1.36 | -5.83 | 0.97 | 0.78 | |
EV to free cash flow | -27.56 | 1.32 | -5.57 | 0.94 | 0.76 | |
Earnings yield | -0.04 | -1.03 | -0.1 | -0.66 | -11.15 | |
Free cash flow yield | -0.04 | -0.58 | -0.1 | -0.49 | -8.2 | |
Debt to equity | 0 | 0.03 | 0.01 | 0 | 0.01 | |
Debt to assets | 0 | 0.02 | 0.01 | 0 | 0.01 | |
Net debt to EBITDA | 0.82 | 1.73 | 4.14 | 2.27 | 0.66 | |
Current ratio | 5.5 | 10.17 | 16.42 | 10.07 | 8.18 | |
Interest coverage | -1.37K | -1.29K | -1.21K | -864.69 | -1.72K | |
Income quality | 0.78 | 0.54 | 0.97 | 0.72 | 0.72 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 2.35 | 2.43 | 0.77 | 0.63 | 0.68 | |
Research and developement to revenue | 1.86 | 0.59 | 0.51 | 0.47 | 0.4 | |
Intangibles to total assets | 0.01 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.08 | 0.04 | 0.05 | 0.03 | 0.03 | |
Capex to revenue | -0.27 | -0.06 | -0.04 | -0.01 | -0.02 | |
Capex to depreciation | -5.49 | -1.82 | -1.64 | -0.72 | -0.92 | |
Stock based compensation to revenue | 0.36 | 1.16 | 0.19 | 0.19 | 0.2 | |
Graham number | 1.7 | 2.58 | 2.32 | 20.64 | 1.99 | |
ROIC | -1.73 | -0.56 | -0.23 | 0.11 | -0.32 | |
Return on tangible assets | -0.97 | -0.51 | -0.21 | -0.22 | -0.27 | |
Graham Net | 0.27 | 0.65 | 0.95 | 4.36 | 0.62 | |
Working capital | 19.82M | 70.68M | 113.94M | 114.21M | 76.77M | |
Tangible asset value | 20.64M | 72.04M | 115.18M | 146.47M | 84.28M | |
Net current asset value | 19.35M | 68.33M | 111.48M | 114.21M | 73.93M | |
Invested capital | 0 | 0.03 | 0.01 | 0 | 0.01 | |
Average receivables | 3.05M | 2.26M | 4.92M | 3.7M | 2.48M | |
Average payables | 3.25M | 4.14M | 3.73M | 3.42M | 3.36M | |
Average inventory | 794.93K | 932.9K | 1.39M | 2.29M | 2.53M | |
Days sales outstanding | 141.17 | 62.24 | 92.44 | 0 | 52.6 | |
Days payables outstanding | 1.21K | 531.97 | 191.43 | 161.93 | 181.38 | |
Days of inventory on hand | 227.4 | 138.12 | 101.05 | 127.49 | 128.39 | |
Receivables turnover | 2.59 | 5.86 | 3.95 | 0 | 6.94 | |
Payables turnover | 0.3 | 0.69 | 1.91 | 2.25 | 2.01 | |
Inventory turnover | 1.61 | 2.64 | 3.61 | 2.86 | 2.84 | |
ROE | -1.18 | -0.58 | -0.23 | 0.11 | -0.31 | |
Capex per share | -0.02 | -0.01 | -0.01 | -0.03 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.07 | 0.08 | 0.08 | 0.09 | 53.72 | |
Net income per share | -0.04 | -0.04 | -0.07 | -0.08 | -34.3 | |
Operating cash flow per share | -0.02 | -0.03 | -0.07 | -0.07 | -22 | |
Free cash flow per share | -0.02 | -0.03 | -0.07 | -0.07 | -22 | |
Cash per share | 0.67 | 0.63 | 0.58 | 0.52 | 236.67 | |
Book value per share | 0.7 | 0.68 | 0.62 | 0.54 | 247.93 | |
Tangible book value per share | 0.7 | 0.67 | 0.61 | 0.54 | 248.6 | |
Share holders equity per share | 0.7 | 0.68 | 0.62 | 0.54 | 247.93 | |
Interest debt per share | 0.01 | 0.01 | 0.01 | 0.01 | 7.22 | |
Market cap | 125.03K | 2.64M | 315.03M | 378.6M | 678.23K | |
Enterprise value | -22.37M | -14.61M | 288.85M | 342.16M | -48.33M | |
P/E ratio | -0.01 | -0.12 | -8.54 | -9.11 | -0.02 | |
Price to sales ratio | 0.01 | 0.28 | 29.86 | 32.21 | 0.05 | |
POCF ratio | -0.05 | -0.77 | -34.72 | -41.6 | -0.12 | |
PFCF ratio | -0.04 | -0.75 | -33.61 | -40.25 | -0.12 | |
P/B Ratio | 0 | 0.03 | 4.06 | 5.52 | 0.01 | |
PTB ratio | 0 | 0.03 | 4.06 | 5.52 | 0.01 | |
EV to sales | -2.46 | -1.54 | 27.38 | 29.11 | -3.54 | |
Enterprise value over EBITDA | 4.11 | 2.81 | -31.91 | -33.01 | -4.19 | |
EV to operating cash flow | 8.05 | 4.25 | -31.84 | -37.6 | 8.65 | |
EV to free cash flow | 7.71 | 4.14 | -30.81 | -36.38 | 8.65 | |
Earnings yield | -44.69 | -2.03 | -0.03 | -0.03 | -12.85 | |
Free cash flow yield | -23.21 | -1.34 | -0.03 | -0.02 | -8.24 | |
Debt to equity | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 | |
Debt to assets | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | |
Net debt to EBITDA | 4.13 | 3.32 | 2.89 | 3.52 | -4.24 | |
Current ratio | 9.64 | 8.18 | 7.21 | 5.61 | 6.25 | |
Interest coverage | -958 | -984.67 | -2.48K | -1.6K | -1.15K | |
Income quality | 0.5 | 0.64 | 0.98 | 0.88 | 1 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.55 | 0.56 | 0.79 | 0.52 | 0.45 | |
Research and developement to revenue | 0.42 | 0.36 | 0.43 | 0.43 | 0.32 | |
Intangibles to total assets | 0 | 0 | 0 | 0.01 | 0.01 | |
Capex to operating cash flow | 0.05 | 0.03 | 0.03 | 0.03 | 0 | |
Capex to revenue | -0.01 | -0.01 | -0.03 | -0.03 | 0 | |
Capex to depreciation | -0.91 | -0.69 | -2.23 | -2.08 | 0 | |
Stock based compensation to revenue | 0.16 | 0.13 | 0.25 | 0.1 | 0 | |
Graham number | 0.84 | 0.81 | 1.01 | 1 | 437.4 | |
ROIC | -0.06 | -0.07 | -0.12 | -0.16 | 0.17 | |
Return on tangible assets | -0.06 | -0.05 | -0.1 | -0.12 | -0.11 | |
Graham Net | 0.61 | 0.56 | 0.51 | 0.43 | 194.1 | |
Working capital | 82.21M | 76.77M | 71.28M | 63.69M | 62.09M | |
Tangible asset value | 87.54M | 84.28M | 77.1M | 68.19M | 63.15M | |
Net current asset value | 79.77M | 73.93M | 67.7M | 59.81M | 56.52M | |
Invested capital | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 | |
Average receivables | 4.45M | 4.73M | 5.07M | 5.69M | 6.04M | |
Average payables | 3.05M | 3.3M | 3.38M | 3.79M | 1.92M | |
Average inventory | 1.99M | 2.04M | 2.47M | 2.93M | 3.72M | |
Days sales outstanding | 44.62 | 47.21 | 44.2 | 47.45 | 38.75 | |
Days payables outstanding | 211.65 | 200.58 | 202.57 | 156.68 | 0 | |
Days of inventory on hand | 115.29 | 141.98 | 151.76 | 124.87 | 186.43 | |
Receivables turnover | 2.02 | 1.91 | 2.04 | 1.9 | 2.32 | |
Payables turnover | 0.43 | 0.45 | 0.44 | 0.57 | 0 | |
Inventory turnover | 0.78 | 0.63 | 0.59 | 0.72 | 0.48 | |
ROE | -0.06 | -0.06 | -0.12 | -0.15 | -0.14 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
AVHHL Frequently Asked Questions
What is AVITA Medical, Inc. stock symbol ?
AVITA Medical, Inc. is a US stock , located in Valencia of Ca and trading under the symbol AVHHL
What is AVITA Medical, Inc. stock quote today ?
AVITA Medical, Inc. stock price is $3.2 today.
Is AVITA Medical, Inc. stock public?
Yes, AVITA Medical, Inc. is a publicly traded company.